✦ LIBER ✦

Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

✍ Scribed by Yamamoto, N; Fukuoka, M; Negoro, S-I; Nakagawa, K; Saito, H; Matsui, K; Kawahara, M; Senba, H; Takada, Y; Kudoh, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan plus gemcitabine vs irinoteca

✍ Georgoulias, V; Kouroussis, C; Agelidou, A; Boukovinas, I; Palamidas, P; Stavrin 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Phase I/II study of docetaxel and cispla

✍ Kiura, K; Ueoka, H; Segawa, Y; Tabata, M; Kamei, H; Takigawa, N; Hiraki, S; Wata 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Phase II study of weekly docetaxel combi

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Phase II study with fractionated schedul

✍ Jung Hye Kwon; Jung Han Kim; Jung-Ae Lee; Hyun Chun Shin; Hyo Jung Kim; Hun Ho S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 193 KB

A Phase II Study of the Docetaxel–Carbop

✍ Nicolas Tsavaris; Christos Kosmas; Elias Skopelitis; Kostantinos Gennatas; Alexa 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 111 KB

Carboplatin and docetaxel in advanced no

✍ Sakkaraiappan Ramalingam; TracyW. Dobbs; AviI. Einzig; Slawomir Wojtowicz-Praga; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 181 KB